WANG Zhe-ming, LI Yi-tong, WANG Zi-qian, ZHANG Zhi-chao. Development of hydrophobic tag-based protein degraders for Bcl-2/Mcl-1 ubiquitination degradationJ. Acta Pharmaceutica Sinica, 2024, 59(11): 2990-2996. DOI: 10.16438/j.0513-4870.2024-0659
Citation: WANG Zhe-ming, LI Yi-tong, WANG Zi-qian, ZHANG Zhi-chao. Development of hydrophobic tag-based protein degraders for Bcl-2/Mcl-1 ubiquitination degradationJ. Acta Pharmaceutica Sinica, 2024, 59(11): 2990-2996. DOI: 10.16438/j.0513-4870.2024-0659

Development of hydrophobic tag-based protein degraders for Bcl-2/Mcl-1 ubiquitination degradation

  • The anti-apoptotic members of Bcl-2 family proteins, Bcl-2 and Mcl-1, are considered therapeutic targets of various cancers. In this article, we developed four hydrophobic tag (HyT)-based protein degraders of Bcl-2/Mcl-1, based on a Bcl-2/Mcl-1 dual inhibitor S1-6, and tested their capability in Bcl-2/Mcl-1 degradation and apoptotic induction in MCF-7 cells. Interestingly, different linkers in the HyT degraders led to selective Bcl-2/Mcl-1 degradation, though the degraders S1-D1-S1-D4 maintained the pan-Bcl-2 family binding capacity. Among them, S1-D2 and S1-D4, two compounds bearing a hydrophobic linker or a PEG linker, were observed to potently and selectively induce the ubiquitination and proteasomal degradation of Bcl-2 and Mcl-1 in living cells, with a degradation rate of more than 80% or 60%, respectively. Moreover, the HyT-based degraders showed increased lethality of cancer cells compared to the parent inhibitor S1-6, demonstrating that the advantage of degraders to the occupancy-based inhibitors.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return